Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

Author： Hochberg Marc C. Berry Scott Broglio Kristine Rosenblatt Lisa Nadkarni Anagha Trivedi Digisha Hebden Tony

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.10, 2013-10, pp. : 1213-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis

By Turkstra E. Ng S.-K. Scuffham P.A.

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1885-1897

Informa Healthcare

Access to resources Recommend Favorite

Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy

By Strehblow Christoph

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Treatment With Anti–Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I–Positive Patients With Rheumatoid Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 5, 2014-05 ,pp. : 788-792

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Biologic Agents With and Without Concomitant Methotrexate and at Reduced Doses in Older Rheumatoid Arthritis Patients

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 5, 2015-05 ,pp. : 624-632

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1478-1488

John Wiley & Sons Inc

Access to resources Recommend Favorite